Leesa F. Wockner

Leesa F. Wockner

Auto-generated profile, based on publicly available information

Leesa F. Wockner

QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2014 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
LWL F Wockner
L F Wockner
ENE P Noble
E P Noble
BLB R Lawford
B R Lawford
RYR McD Young
R McD Young
CMCharles Morris
Charles Morris
JVJoanne Voisey
Joanne Voisey
Recent studies suggest that genetic and environmental factors do not account for all the schizophrenia risk, and epigenetics also has a role in disease susceptibility. DNA methylation is a heritable epigenetic modification that can regulate gene expression. Genome-wide DNA methylation analysis was performed on post-mortem human brain tissue from 24 patients with schizophrenia and 24 unaffected controls. DNA methylation was assessed at over 485 000 CpG sites using the Illumina Infinium HumanMethylation450 Bead Chip. After adjusting for age and post-mortem interval, 4641 probes corresponding to 2929 unique genes were found to be differentially methylated. Of those genes, 1291 were located in a CpG island and 817 were in a promoter region. These includeNOS1,AKT1,DTNBP1,DNMT1,PPP3CCandSOX10, which have previously been associated with schizophrenia. More than 100 of these genes overlap with a previous DNA methylation study of peripheral blood from schizophrenia patients in which 27 000 CpG sites were analysed. Unsupervised clustering analysis of the top 3000 most variable probes revealed two distinct groups with significantly more people with schizophrenia in cluster one compared with controls (P=1.74 × 10−4). The first cluster composed of 88% of patients with schizophrenia and only 12% controls, whereas the second cluster composed of 27% of patients with schizophrenia and 73% controls. These results strongly suggest that differential DNA methylation is important in schizophrenia etiology and add support for the use of DNA methylation profiles as a future prognostic indicator of schizophrenia.

1 March 2014 in Critical Care Medicine
Verified
Journal Article
Closed access
AUAndrew A. Udy
Andrew A. Udy
JBJoão P. Baptista
João P. Baptista
NLNoelle L. Lim
Noelle L. Lim
GJGavin Matthew Joynt
Gavin Matthew Joynt
PJPaul Jarrett
Paul Jarrett
Jeffrey LipmanJeffrey Lipman
Jeffrey Lipman
To describe the prevalence and natural history of augmented renal clearance in a cohort of recently admitted critically ill patients with normal plasma creatinine concentrations. Multicenter, prospective, observational study. Four, tertiary-level, university-affiliated, ICUs in Australia, Singapore, Hong Kong, and Portugal. Study participants had to have an expected ICU length of stay more than 24 hours, no evidence of absolute renal impairment (admission plasma creatinine < 120 µmol/L), and no history of prior renal replacement therapy or chronic kidney disease. Convenience sampling was used at each participating site. Eight-hour urinary creatinine clearances were collected daily, as the primary method of measuring renal function. Augmented renal clearance was defined by a creatinine clearance more than or equal to 130 mL/min/1.73 m. Additional demographic, physiological, therapeutic, and outcome data were recorded prospectively. Nine hundred thirty-two patients were admitted to the participating ICUs over the study period, and 281 of which were recruited into the study, contributing 1,660 individual creatinine clearance measures. The mean age (95% CI) was 54.4 years (52.5-56.4 yr), Acute Physiology and Chronic Health Evaluation II score was 16 (15.2-16.7), and ICU mortality was 8.5%. Overall, 65.1% manifested augmented renal clearance on at least one occasion during the first seven study days; the majority (74%) of whom did so on more than or equal to 50% of their creatinine clearance measures. Using a mixed-effects model, the presence of augmented renal clearance on study day 1 strongly predicted (p = 0.019) sustained elevation of creatinine clearance in these patients over the first week in ICU. Augmented renal clearance appears to be a common finding in this patient group, with sustained elevation of creatinine clearance throughout the first week in ICU. Future studies should focus on the implications for accurate dosing of renally eliminated pharmaceuticals in patients with augmented renal clearance, in addition to the potential impact on individual clinical outcomes.

13 September 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
HTHazel Tye
Hazel Tye
CYChien-Hsiung Yu
Chien-Hsiung Yu
LSLisa A. Simms
Lisa A. Simms
MZMarcel R. de Zoete
Marcel R. de Zoete
MKMan Lyang Kim
Man Lyang Kim
SMSeth L. Masters
Seth L. Masters
Anti-microbial signaling pathways are normally triggered by innate immune receptors when detecting pathogenic microbes to provide protective immunity. Here we show that the inflammasome sensor Nlrp1 aggravates DSS-induced experimental mouse colitis by limiting beneficial, butyrate-producingClostridialesin the gut. The colitis-protective effects ofNlrp1deficiency are thus reversed by vancomycin treatment, but recapitulated with butyrate supplementation in wild-type mice. Moreover, an activating mutation inNlrp1aincreases IL-18 and IFNγ production, and decreases colonic butyrate to exacerbate colitis. We also show that, in patients with ulcerative colitis, increasedNLRP1in inflamed regions of the colon is associated with increasedIFN-γ. In this context,NLRP1,IL-18orIFN-γexpression negatively correlates with the abundance ofClostridialesin human rectal mucosal biopsies. Our data identify the NLRP1 inflammasome to be a key negative regulator of protective, butyrate-producing commensals, which therefore promotes inflammatory bowel disease.

20 September 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
CBCatherine E. Bond
Catherine E. Bond
DMDiane M. McKeone
Diane M. McKeone
MKMurugan Kalimutho
Murugan Kalimutho
MBMark Bettington
Mark Bettington
SPSally-Ann Pearson
Sally-Ann Pearson
VWVicki L.J. Whitehall
Vicki L.J. Whitehall
RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis

1 February 2014 in American Journal of Surgical Pathology
Verified
Journal Article
Closed access
MBMark Bettington
Mark Bettington
NWNeal Walker
Neal Walker
CRChristophe Rosty
Christophe Rosty
IBIan Brown
Ian Brown
ACAndrew Clouston
Andrew Clouston
BLBarbara Leggett
Barbara Leggett
The sessile serrated adenoma (SSA) is a relatively recently described polyp that can present diagnostic difficulties for the practicing pathologist. The frequency of SSA diagnoses varies dramatically in the reported literature. In addition, the histologic interface between the microvesicular hyperplastic polyp (MVHP) and the SSA continues to be a diagnostic problem. The trend in recent years has been toward a lower threshold for SSA diagnosis. Herein, we have performed a cross-sectional study of 6340 colorectal polyps received at a high-volume community-based pathology practice over a 3-month period. After central review, with strict application of the diagnostic criteria outlined in the 2010 edition of the World Health Organization Classification of Tumours of the Digestive Tract, we found that SSAs represented 12.1% of all polyps. In addition, we developed novel diagnostic subcategories in an attempt to determine the most appropriate cutoff for the interface between the MVHP and the SSA. We found that serrated polyps (MVHPs or SSAs) with any SSA-like crypts had clinical features more in common with the SSA than the MVHP and that this diagnostic cutoff showed good reproducibility between pathologists. This supports the position of a recent consensus publication proposing that polyps with as few as 1 SSA-type crypt should be diagnosed as an SSA. Applying these criteria to our cohort yields an overall SSA rate of 14.7%. In summary, we believe that SSAs continue to be underdiagnosed in pathologic practice and that this may result in inadequate surveillance and thus contribute to interval colorectal carcinomas.

1 May 2016 in Contemporary Clinical Trials
Verified
Journal Article
Closed access
RNRachel Neale
Rachel Neale
BAB.K. Armstrong
B.K. Armstrong
CBC. Baxter
C. Baxter
BRB. Duarte Romero
B. Duarte Romero
PEP. Ebeling
P. Ebeling
LWL. Wockner
L. Wockner